BioLife Solutions Company Insiders
| BLFS Stock | USD 25.06 0.42 1.65% |
BioLife Solutions employs about 159 people. The company is managed by 11 executives with a total tenure of roughly 48 years, averaging almost 4.0 years of service per executive, having 14.45 employees per reported executive. Breaking down BioLife Solutions' management performance can provide insight into the firm performance.
| Michael Rice CEO CEO and President and Director |
| Aby Mathew Chairman Chairman of Scientific Advisory Board, CTO and Sr. VP |
BioLife |
BioLife Solutions Management Team Effectiveness
The company has return on total asset (ROA) of (0.011) % which means that it has lost $0.011 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.0332) %, meaning that it created substantial loss on money invested by shareholders. BioLife Solutions' management efficiency ratios could be used to measure how well BioLife Solutions manages its routine affairs as well as how well it operates its assets and liabilities.BioLife Solutions Workforce Comparison
BioLife Solutions is rated below average in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 102,244. BioLife Solutions adds roughly 159 in number of employees claiming only tiny portion of equities under Health Care industry.
The company has Profit Margin (PM) of (0.25) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.4) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.4. BioLife Solutions Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific BioLife Solutions insiders, such as employees or executives, is commonly permitted as long as it does not rely on BioLife Solutions' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, BioLife Solutions insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Karen Foster 2 days ago Disposition of 324 shares by Karen Foster of BioLife Solutions at 25.46 subject to Rule 16b-3 | ||
Aebersold Sarah few days ago Disposition of 2695 shares by Aebersold Sarah of BioLife Solutions at 25.44 subject to Rule 16b-3 | ||
Aebersold Sarah over a week ago Disposition of 7324 shares by Aebersold Sarah of BioLife Solutions at 26.34 subject to Rule 16b-3 | ||
Troy Wichterman over a week ago Disposition of 4151 shares by Troy Wichterman of BioLife Solutions at 25.0 subject to Rule 16b-3 | ||
Aby Mathew over two weeks ago Disposition of 17604 shares by Aby Mathew of BioLife Solutions at 20.05 subject to Rule 16b-3 | ||
Troy Wichterman over two months ago Disposition of 987 shares by Troy Wichterman of BioLife Solutions at 27.02 subject to Rule 16b-3 | ||
Aby Mathew over three months ago Disposition of 13196 shares by Aby Mathew of BioLife Solutions at 27.16 subject to Rule 16b-3 | ||
Sean Werner over three months ago Insider Trading |
BioLife Solutions Notable Stakeholders
A BioLife Solutions stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BioLife Solutions often face trade-offs trying to please all of them. BioLife Solutions' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BioLife Solutions' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Michael Rice | CEO and President and Director | Profile | |
| Aby Mathew | Chairman of Scientific Advisory Board, CTO and Sr. VP | Profile | |
| Todd Berard | Vice President of Marketing | Profile | |
| Karen Foster | Vice President - Operations | Profile | |
| Roderick Greef | Interim CFO, Interim Secretary | Profile | |
| Sarah JD | Chief Officer | Profile | |
| Troy Wichterman | Chief Officer | Profile | |
| Geraint Phillips | Senior Operations | Profile | |
| Troy CPA | Chief Officer | Profile | |
| Sean Werner | Chief Officer | Profile | |
| Marcus Schulz | Chief Officer | Profile |
About BioLife Solutions Management Performance
The success or failure of an entity such as BioLife Solutions often depends on how effective the management is. BioLife Solutions management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BioLife management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BioLife management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. BioLife Solutions, Inc. was incorporated in 1987 and is headquartered in Bothell, Washington. Biolife Solutions operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 432 people.
Please note, the imprecision that can be found in BioLife Solutions' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of BioLife Solutions. Check BioLife Solutions' Beneish M Score to see the likelihood of BioLife Solutions' management manipulating its earnings.
BioLife Solutions Workforce Analysis
Traditionally, organizations such as BioLife Solutions use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BioLife Solutions within its industry.BioLife Solutions Manpower Efficiency
Return on BioLife Solutions Manpower
| Revenue Per Employee | 517.3K | |
| Revenue Per Executive | 7.5M | |
| Net Loss Per Employee | 126.9K | |
| Net Loss Per Executive | 1.8M | |
| Working Capital Per Employee | 729.7K | |
| Working Capital Per Executive | 10.5M |
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.